市場調査レポート
商品コード
1420110

抗生剤の世界市場(2024年版):薬剤クラス別、スペクトラム別、適応症別、地域別、国別の分析、市場考察、予測(2019年~2029年)

Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

出版日: | 発行: Azoth Analytics | ページ情報: 英文 260 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
抗生剤の世界市場(2024年版):薬剤クラス別、スペクトラム別、適応症別、地域別、国別の分析、市場考察、予測(2019年~2029年)
出版日: 2024年02月01日
発行: Azoth Analytics
ページ情報: 英文 260 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗生剤の市場規模は、2022年の504億1,000万米ドルから2029年末までに739億2,000万米ドルに達し、予測期間の2024年~2029年にCAGRで4.7%の成長が見込まれています。を創出する見込みです。市場は長年にわたり安定した成長を示しています。細菌感染症の増加、抗生剤耐性の永続的な進化が、革新的な抗生剤療法の需要を後押ししています。市場は、セファロスポリン系、フルオロキノロン系、マクロライド系、テトラサイクリン系などの多様な抗生剤によって特徴付けられ、それぞれが細菌感染症への対処において明確な役割を果たしています。

医療コミュニティと社会全体において、迅速かつ効率的な抗生剤治療の重要性が認識されるようになり、需要が増加しています。責任ある抗生剤の使用を提唱し、抗生剤耐性の影響に関する教育を提供するプログラムは、市場動向に影響を与える重要な役割を果たしています。抗生剤耐性の脅威の高まりは、新しい抗生剤を開発し、既存の抗生剤の有効性を維持する世界的な活動を促しています。製薬企業、研究機関、政府機関の共同的な取り組みは、この重大な医療課題に対処することを目的としています。

当レポートでは、世界の抗生剤市場について調査し、市場規模と予測、地域とセグメントの分析、主要動向と機会などの情報を提供しています。

目次

第1章 市場の背景

  • 範囲と製品の見通し
  • エグゼクティブサマリー
  • 調査手法

第2章 戦略的推奨事項

第3章 世界の抗生剤市場:実績と予測(2019年~2029年)

  • 世界の感染症の有病率(2019年)
  • 感染症の世界の発症率(2019年)
  • 外来でもっとも処方されている上位10の抗生剤
  • 世界の抗生剤市場:ダッシュボード
  • 世界の抗生剤市場:市場金額の評価(2019年~2029年)
  • 世界の抗生剤市場に対するCOVID-19の影響
  • 世界の抗生剤市場セグメンテーション:薬剤クラス別
    • 世界の抗生剤市場:薬剤クラス別、概要
    • 世界の抗生剤の市場規模:セファロスポリン(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:ペニシリン(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:マクロライド(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:フルオロキノロン(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:その他の薬剤クラス(金額)(2019年~2029年)
  • 世界の抗生剤市場セグメンテーション:スペクトラム別
    • 世界の抗生剤市場:スペクトラム別、概要
    • 世界の抗生剤の市場規模:広域(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:狭域(金額)(2019年~2029年)
  • 世界の抗生剤市場セグメンテーション:適応症別
    • 世界の抗生剤市場:適応症別、概要
    • 世界の抗生剤の市場規模:肺炎(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:髄膜炎(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:胃腸感染症(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:尿路感染症(金額)(2019年~2029年)
    • 世界の抗生剤の市場規模:その他の適応症(金額)(2019年~2029年)

第4章 世界の抗生剤市場、地域分析

  • 研究の地域範囲
  • 地域のスナップショット

第5章 南北アメリカの抗生剤市場:実績と予測(2019年~2029年)

  • 南北アメリカの抗生剤市場:スナップショット
  • 南北アメリカの抗生剤市場:市場規模とCAGR(2019年~2029年)
  • 南北アメリカの抗生剤市場:主な要因
  • 南北アメリカの抗生剤市場:セグメント分析
  • 南北アメリカの抗生剤市場セグメンテーション:薬剤クラス別
  • 南北アメリカの抗生剤市場セグメンテーション:スペクトラム別
  • 南北アメリカの抗生剤市場セグメンテーション:適応症別
  • 南北アメリカの抗生剤市場セグメンテーション:国別
    • 米国の抗生剤市場:市場規模とCAGR(2019年~2029年)
    • カナダの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • その他の南北アメリカの抗生剤市場:市場規模とCAGR(2019年~2029年)

第6章 欧州の抗生剤市場:実績と予測(2019年~2029年)

  • 欧州の抗生剤市場:スナップショット
  • 欧州の抗生剤市場:市場規模とCAGR(2019年~2029年)
  • 欧州の抗生剤市場:主な要因
  • 欧州の抗生剤市場:セグメント分析
  • 欧州の抗生剤市場セグメンテーション:薬剤クラス別
  • 欧州の抗生剤市場セグメンテーション:スペクトラム別
  • 欧州の抗生剤市場セグメンテーション:適応症別
  • 欧州の抗生剤市場セグメンテーション:国別
    • ドイツの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • 英国の抗生剤市場:市場規模とCAGR(2019年~2029年)
    • フランスの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • イタリアの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • スペインの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • その他の欧州の抗生剤市場:市場規模とCAGR(2019年~2029年)

第7章 アジア太平洋の抗生剤市場:実績と予測(2019年~2029年)

  • アジア太平洋の抗生剤市場:スナップショット
  • アジア太平洋の抗生剤市場:市場規模とCAGR(2019年~2029年)
  • アジア太平洋の抗生剤市場:主な要因
  • アジア太平洋の抗生剤市場:セグメント分析
  • アジア太平洋の抗生剤市場セグメンテーション:薬剤クラス別
  • アジア太平洋の抗生剤市場セグメンテーション:スペクトラム別
  • アジア太平洋の抗生剤市場セグメンテーション:適応症別
  • アジア太平洋の抗生剤市場セグメンテーション:国別
    • 中国の抗生剤市場:市場規模とCAGR(2019年~2029年)
    • 日本の抗生剤市場:市場規模とCAGR(2019年~2029年)
    • インドの抗生剤市場:市場規模とCAGR(2019年~2029年)
    • その他のアジア太平洋の抗生剤市場:市場規模とCAGR(2019年~2029年)

第8章 中東・アフリカの抗生剤市場:実績と予測(2019年~2029年)

  • 中東・アフリカの抗生剤市場:スナップショット
  • 中東・アフリカの抗生剤市場:市場規模とCAGR(2019年~2029年)
  • 中東・アフリカの抗生剤市場:主な要因
  • 中東・アフリカの抗生剤市場:セグメント分析
  • 中東・アフリカの抗生剤市場セグメンテーション:薬剤クラス別
  • 中東・アフリカの抗生剤市場セグメンテーション:スペクトラム別
  • 中東・アフリカの抗生剤市場セグメンテーション:適応症別
    • 中東・アフリカの抗生剤市場、適応症別:概要
    • 中東・アフリカの抗生剤の市場規模:肺炎(金額)(2019年~2029年)
    • 中東・アフリカの抗生剤の市場規模:髄膜炎(金額)(2019年~2029年)
    • 中東・アフリカの抗生剤の市場規模:胃腸感染症(金額)(2019年~2029年)
    • 中東・アフリカの抗生剤の市場規模:尿路感染症(金額)(2019年~2029年)
    • 中東・アフリカの抗生剤の市場規模:その他の適応症(金額)(2019年~2029年)

第9章 市場力学

  • 世界の抗生剤市場に対する市場力学の影響の評価
  • 促進要因
  • 抑制要因
  • 動向

第10章 ポーターのファイブフォース分析

第11章 競合ポジショニング

  • 企業の製品ポジショニング
  • 市場ポジションマトリクス
  • 抗生剤市場の市場シェア分析
  • 企業プロファイル
    • Abbott Laboratories
    • Johnson & Johnson
    • Pfizer
    • GSK PLC
    • Novartis AG
    • Roche Holding AG
    • Bayer AG
    • Merck & Co., Inc.
    • Viatris Inc.
    • Cipla
図表

List of Figures

List of Figures

  • Figure 1: Top 10 most prescribed outpatient antibiotics in 2022 in the United States
  • Figure 2: Global Antibiotic Drugs Market Size, By Value, 2019-2022 (USD Billion)
  • Figure 3: Global Antibiotic Drugs Market Size, By Value, 2023-2029 (USD Billion)
  • Figure 4: Global Antibiotic Drugs Market Share, By Drug Class, 2022 (%)
  • Figure 5: Global Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 6: Global Antibiotic Drugs Market Absolute Opportunity, By Cephalosporin, 2019-2029 (USD Billion)
  • Figure 7: Global Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 8: Global Antibiotic Drugs Market Absolute Opportunity, By Penicillin, 2019-2029 (USD Billion)
  • Figure 9: Global Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 10: Global Antibiotic Drugs Market Absolute Opportunity, By Macrolides, 2019-2029 (USD Billion)
  • Figure 11: Global Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 12: Global Antibiotic Drugs Market Absolute Opportunity, By Fluoroquinolone, 2019-2029 (USD Billion)
  • Figure 13: Global Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 14: Global Antibiotic Drugs Market Absolute Opportunity, By Other Drug Classes, 2019-2029 (USD Billion)
  • Figure 15: Global Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 16: Global Antibiotic Drugs Market Absolute Opportunity, By Broad Spectrum, 2019-2029 (USD Billion)
  • Figure 17: Global Antibiotic Drugs Market Size, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 18: Global Antibiotic Drugs Market Absolute Opportunity, By Narrow spectrum, 2019-2029 (USD Billion)
  • Figure 19: Global Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 20: Global Antibiotic Drugs Market Absolute Opportunity, By Pneumonia, 2019-2029 (USD Billion)
  • Figure 21: Global Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 22: Global Antibiotic Drugs Market Absolute Opportunity, By Meningitis, 2019-2029 (USD Billion)
  • Figure 23: Global Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 24: Global Antibiotic Drugs Market Absolute Opportunity, By Gastrointestinal infections, 2019-2029 (USD Billion)
  • Figure 25: Global Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 26: Global Antibiotic Drugs Market Absolute Opportunity, By Urinary Tract Infections, 2019-2029 (USD Billion)
  • Figure 27: Global Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 28: Global Antibiotic Drugs Market Absolute Opportunity, By Other Indications, 2019-2029 (USD Billion)
  • Figure 29: Americas Antibiotic Drugs Market Size, By Value, 2019H-2029F (USD Billion)
  • Figure 30: Americas Antibiotic Drugs Market Share, By Drug Class, 2022 (%)
  • Figure 31: Americas Antibiotic Drugs Market, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 32: Americas Antibiotic Drugs Market, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 33: Americas Antibiotic Drugs Market, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 34: Americas Antibiotic Drugs Market, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 35: Americas Antibiotic Drugs Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 36: Americas Antibiotic Drugs Market, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 37: Americas Antibiotic Drugs Market, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 38: Americas Antibiotic Drugs Market, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 39: Americas Antibiotic Drugs Market, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 40: Americas Antibiotic Drugs Market, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 41: Americas Antibiotic Drugs Market, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 42: Americas Antibiotic Drugs Market, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 43: United States Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 44: United States Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 45: United States Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 46: United States Antibiotic Drugs Market Share, By Spectrum, By Value, 2022 (%)
  • Figure 47: United States Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 48: Canada Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 49: Canada Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 50: Canada Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 51: Canada Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 52: Canada Antibiotic Drugs Market Share, Indication, 2022 (%)
  • Figure 53: Rest of Americas Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 54: Rest of Americas Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 55: Rest of Americas Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 56: Rest of Americas Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 57: Rest of Americas Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 58: Europe Antibiotic Drugs Market Size, By Value, 2019H-2029F (USD Billion)
  • Figure 59: Europe Antibiotic Drugs Market Share, By Drug Class, 2022 (%)
  • Figure 60: Europe Antibiotic Drugs Market, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 61: Europe Antibiotic Drugs Market, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 62: Europe Antibiotic Drugs Market, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 63: Europe Antibiotic Drugs Market, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 64: Europe Antibiotic Drugs Market, By Other Drug classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 65: Europe Antibiotic Drugs Market, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 66: Europe Antibiotic Drugs Market, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 67: Europe Antibiotic Drugs Market, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 68: Europe Antibiotic Drugs Market, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 69: Europe Antibiotic Drugs Market, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 70: Europe Antibiotic Drugs Market, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 71: Europe Antibiotic Drugs Market, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 72: Germany Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 73: Germany Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 74: Germany Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 75: Germany Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 76: Germany Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 77: United Kingdom Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 78: United Kingdom Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 79: United Kingdom Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 80: United Kingdom Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 81: United Kingdom Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 82: France Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 83: France Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 84: France Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 85: France Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 86: France Antibiotic Drugs Market Share, By Indication, By Value 2022 (%)
  • Figure 87: Italy Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 88: Italy Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 89: Italy Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 90: Italy Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 91: Italy Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 92: Spain Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 93: Spain Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 94: Spain Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 95: Spain Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 96: Spain Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 97: Rest of Europe Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 98: Rest of Europe Antibiotic Drugs Market Value, By Drug Class, 2022 (USD Billion)
  • Figure 99: Rest of Europe Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 100: Rest of Europe Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 101: Rest of Europe Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 102: Asia Pacific Antibiotic Drugs Market Size, By Value, 2019H-2029F (USD Billion)
  • Figure 103: Asia Pacific Antibiotic Drugs Market Share, By Drug Class, 2022 (%)
  • Figure 104: Asia Pacific Antibiotic Drugs Market, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 105: Asia Pacific Antibiotic Drugs Market, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 106: Asia Pacific Antibiotic Drugs Market, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 107: Asia Pacific Antibiotic Drugs Market, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 108: Asia Pacific Antibiotic Drugs Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 109: Asia Pacific Antibiotic Drugs Market, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 110: Asia Pacific Antibiotic Drugs Market, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 111: Asia Pacific Antibiotic Drugs Market, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 112: Asia Pacific Antibiotic Drugs Market, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 113: Asia Pacific Antibiotic Drugs Market, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 114: Asia Pacific Antibiotic Drugs Market, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 115: Asia Pacific Antibiotic Drugs Market, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 116: China Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 117: China Antibiotic Drugs Market Value, By Spectrum, 2022 (USD Billion)
  • Figure 118: China Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 119: China Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 120: China Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 121: Japan Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 122: Japan Antibiotic Drugs Market Value, By Spectrum, 2022 (USD Billion)
  • Figure 123: Japan Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 124: Japan Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 125: Japan Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 126: India Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 127: India Antibiotic Drugs Market Value, By Spectrum, 2022 (USD Billion)
  • Figure 128: India Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 129: India Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 130: India Antibiotic Drugs Market Share, Indication, 2022 (%)
  • Figure 131: Rest of Asia Pacific Antibiotic Drugs Market, By Value, 2019-2029 (USD Billion & CAGR)
  • Figure 132: Rest of Asia Pacific Antibiotic Drugs Market Value, By Spectrum, 2022 (USD Billion)
  • Figure 133: Rest of Asia Pacific Antibiotic Drugs Market Share, By Drug Class, By Value, 2022 (%)
  • Figure 134: Rest of Asia Pacific Antibiotic Drugs Market Share, By Spectrum, 2022 (%)
  • Figure 135: Rest of Asia Pacific Antibiotic Drugs Market Share, By Indication, 2022 (%)
  • Figure 136: Middle East and Africa Antibiotic Drugs Market Size, By Value, 2019H-2029F (USD Billion)
  • Figure 137: Middle East and Africa Antibiotic Drugs Market Share, By Drug Class, 2022 (%)
  • Figure 138: Middle East and Africa Antibiotic Drugs Market, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 139: Middle East and Africa Antibiotic Drugs Market, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 140: Middle East and Africa Antibiotic Drugs Market, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 141: Middle East and Africa Antibiotic Drugs Market, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 142: Middle East and Africa Antibiotic Drugs Market, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 143: Middle East and Africa Antibiotic Drugs Market, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 144: Middle East and Africa Antibiotic Drugs Market, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 145: Middle East and Africa Antibiotic Drugs Market, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 146: Middle East and Africa Antibiotic Drugs Market, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 147: Middle East and Africa Antibiotic Drugs Market, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 148: Middle East and Africa Antibiotic Drugs Market, By Urinary Tract infections, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 149: Middle East and Africa Antibiotic Drugs Market, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • Figure 150: Market Share of Prominent Companies of Antibiotic Drugs Market, 2022 (%)
  • Figure 151: Abbott Laboratories Revenues, 2020-2022 (USD Million)
  • Figure 152: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
  • Figure 153: Abbott Laboratories Revenue, By Business Segments, 2022 (%)
  • Figure 154: Johnson & Johnson Revenues, 2020-2022 (USD Million)
  • Figure 155: Johnson & Johnson Revenues, By Geographic Segments, 2022 (%)
  • Figure 156: Johnson & Johnson Revenue, By Business Segments, 2022 (%)
  • Figure 157: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 158: Pfizer Revenues, By Business Segments, 2022 (%)
  • Figure 159: Pfizer Inc. Revenue, By Geographical Segments, 2022 (%)
  • Figure 160: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 161: GSK PLC Revenue, By Business Segments, 2022 (%)
  • Figure 162: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 163: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 164: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 165: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 166: Roche Revenue, 2020-2022 (USD Million)
  • Figure 167: Roche Revenue, By Business Segments, 2022 (%)
  • Figure 168: Roche Revenue, By Business Segments, 2022 (%)
  • Figure 169: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 170: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 171: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 172: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 173: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 174: Merck & Co., Inc. Revenue, By Business Segments, 2022 (%)
  • Figure 175: Viatris Revenues, 2020-2022 (USD Million)
  • Figure 176: Viatris Revenues, By Geographic Segments, 2022 (%)
  • Figure 177: Viatris Revenue, By Business Segment, 2022 (%)
  • Figure 178: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 179: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 180: Cipla Revenue, By Business Segments, 2022 (%)

List of Tables

Table A1: United States Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A2: United States Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A3: United States Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A4: United States Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A5: United States Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A6: United States Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A7: Canada Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A8: Canada Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A9: Canada Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A10: Canada Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A11: Canada Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A12: Canada Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A13: Rest of Americas Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A14: Rest of Americas Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A15: Rest of Americas Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A16: Rest of Americas Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A17: Rest of Americas Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A18: Rest of Americas Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A19: Germany Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A20: Germany Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A21: Germany Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A22: Germany Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A23: Germany Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A24: Germany Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A25: United Kingdom Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A26: United Kingdom Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A27: United Kingdom Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A28: United Kingdom Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A29: United Kingdom Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A30: United Kingdom Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A31: France Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A32: France Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A33: France Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A34: France Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A35: France Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A36: France Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A37: Italy Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A38: Italy Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A39: Italy Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A40: Italy Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A41: Italy Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A42: Italy Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A43: Spain Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A44: Spain Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A45: Spain Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A46: Spain Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A47: Spain Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A48: Spain Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A49: Rest of Europe Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A50: Rest of Europe Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A51: Rest of Europe Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A52: Rest of Europe Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A53: Rest of Europe Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A54: Rest of Europe Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A55: China Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A56: China Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A57: China Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A58: China Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A59: China Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A60: China Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A61: Japan Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A62: Japan Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A63: Japan Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A64: Japan Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A65: Japan Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A66: Japan Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A67: India Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A68: India Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A69: India Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A70: India Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A71: India Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A72: India Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A73: Rest of Asia Pacific Antibiotic Drugs Market, By Drug Class, By Value, 2019-2022 (USD Billion)

Table A74: Rest of Asia Pacific Antibiotic Drugs Market, By Drug Class, By Value, 2023-2029 (USD Billion)

Table A75: Rest of Asia Pacific Antibiotic Drugs Market, By Spectrum, By Value, 2019-2022 (USD Billion)

Table A76: Rest of Asia Pacific Antibiotic Drugs Market, By Spectrum, By Value, 2023-2029 (USD Billion)

Table A77: Rest of Asia Pacific Antibiotic Drugs Market, By Indication, By Value, 2019-2022 (USD Billion)

Table A78: Rest of Asia Pacific Antibiotic Drugs Market, By Indication, By Value, 2023-2029 (USD Billion)

Table A79: Abbott Laboratories Key Financials, 2020-2022

Table A80: Johnson & Johnson Key Financials, 2020-2022

Table A81: Pfizer Key Financials, 2020-2022

Table A82: GSK PLC Key Company Financials, 2020-2022

Table A83: Novartis Key Company Financials, 2020-2022

Table A84: Roche Key Company Financials, 2020-2022

Table A85: Bayer AG Key Financials, 2020-2022

Table A86: Merck & Co., Inc. Key Financials, 2020-2022

Table A87: Viatris Key Financials, 2020-2022

Table A88: Cipla Key Financials, 2020-2022

目次

Executive Summary

Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications), By Region and By Country for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Antibiotic Drugs market is expected to grow at a CAGR of 4.7%

The Global Antibiotic Drugs Market is expected to generate USD 73.92 Billion by the end of 2029, up from USD 50.41 Billion in 2022. The antibiotic drugs market has witnessed steady growth over the years. The increasing prevalence of bacterial infections, coupled with the perpetual evolution of antibiotic resistance, propels the demand for innovative antibiotic therapies. The market is characterized by a diverse range of antibiotics, including Cephalosporins, fluoroquinolones, macrolides, and tetracyclines, each playing a distinct role in addressing bacterial infections.

The increased recognition of the significance of prompt and efficient antibiotic treatment within the healthcare community and the general populace catalyse increased demand. Programs advocating for responsible antibiotic usage and providing education about the repercussions of antibiotic resistance play a crucial role in influencing market trends. The escalating threat of antibiotic resistance has prompted concerted global efforts to develop new antibiotics and preserve the effectiveness of existing ones. Collaborative initiatives between pharmaceutical companies, research institutions, and governmental bodies aim to address this critical healthcare challenge.

Scope of the Report

  • The report analyses the Antibiotic Drugs Market by Value (USD Billion).
  • The report presents the analysis of the Antibiotic Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Antibiotic Drugs Market by Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Other Drug Classes).
  • The report analyses the Antibiotic Drugs Market By Spectrum (Broad Spectrum, Narrow Spectrum)
  • The report analyses the Antibiotic Drugs Market By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Drug Class, By Spectrum & By Indication.
  • Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Johnson & Johnson, Pfizer, GSK PLC, Novartis AG, Roche Holding AG, Bayer AG, Merck & Co., Inc., Viatris Inc. and Cipla.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

3. Global Antibiotic Drugs Market: Historic and Forecast (2019-2029)

  • 3.1 Global Prevalence of Infectious Diseases, 2019
  • 3.2 Global Incidence of Infectious Diseases, 2019
  • 3.3 Top 10 most prescribed outpatient antibiotics
  • 3.4 Global Antibiotic Drugs Market: Dashboard
  • 3.5 Global Antibiotic Drugs Market: Market Value Assessment, 2019-2029 (USD Billion)
  • 3.6 Impact of COVID-19 on Global Antibiotic Drugs Market
  • 3.7 Global Antibiotic Drugs Market Segmentation: By Drug Class
    • 3.7.1 Global Antibiotic Drugs Market, By Drug Class Overview
    • 3.7.2 Global Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.7.3 Global Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.7.4 Global Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.7.5 Global Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.7.6 Global Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8 Global Antibiotic Drugs Market Segmentation: By Spectrum
    • 3.8.1 Global Antibiotic Drugs Market, By Spectrum Overview
    • 3.8.2 Global Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.8.3 Global Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9 Global Antibiotic Drugs Market Segmentation: By Indication
    • 3.9.1 Global Antibiotic Drugs Market, By Indication Overview
    • 3.9.2 Global Antibiotic Drugs Market Size, By Pneumonia By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.9.3 Global Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.9.4 Global Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.9.5 Global Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 3.9.6 Global Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Antibiotic Drugs Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Antibiotic Drugs Market: Historic and Forecast (2019-2029)

  • 5.1 Americas Antibiotic Drugs Market: Snapshot
  • 5.2 Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
  • 5.3 Americas Antibiotic Drugs Market: Key Factors
  • 5.4 Americas Antibiotic Drugs Market: Segment Analysis
  • 5.5 Americas Antibiotic Drugs Market Segmentation: By Drug Class
    • 5.5.1 Americas Antibiotic Drugs Market, By Drug Class Overview
    • 5.5.2 Americas Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.5.3 Americas Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.5.4 Americas Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.5.5 Americas Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.5.6 Americas Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6 Americas Antibiotic Drugs Market Segmentation: By Spectrum
    • 5.6.1 Americas Antibiotic Drugs Market, By Spectrum Overview
    • 5.6.2 Americas Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.6.3 Americas Antibiotic Drugs Market Size, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7 Americas Antibiotic Drugs Market Segmentation: By Indication
    • 5.7.1 Americas Antibiotic Drugs Market, By Indication Overview
    • 5.7.2 Americas Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.7.3 Americas Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.7.4 Americas Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.7.5 Americas Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 5.7.6 Americas Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.8 Americas Antibiotic Drugs Market Segmentation: By Country
    • 5.8.1 United States Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 5.8.1.1 United States Antibiotic Drugs Market, By Drug Class
      • 5.8.1.2 United States Antibiotic Drugs Market, By Spectrum
      • 5.8.1.3 United States Antibiotic Drugs Market, By Indication
    • 5.8.2 Canada Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 5.8.2.1 Canada Antibiotic Drugs Market, By Drug Class
      • 5.8.2.2 Canada Antibiotic Drugs Market, By Spectrum
      • 5.8.2.3 Canada Antibiotic Drugs Market, By Indication
    • 5.8.3 Rest of Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 5.8.3.1 Rest of Americas Antibiotic Drugs Market, By Drug Class
      • 5.8.3.2 Rest of Americas Antibiotic Drugs Market, By Spectrum
      • 5.8.3.3 Rest of Americas Antibiotic Drugs Market, By Indication

6. Europe Antibiotic Drugs Market: Historic and Forecast (2019-2029)

  • 6.1 Europe Antibiotic Drugs Market: Snapshot
  • 6.2 Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
  • 6.3 Europe Antibiotic Drugs Market: Key Factors
  • 6.4 Europe Antibiotic Drugs Market: Segment Analysis
  • 6.5 Europe Antibiotic Drugs Market Segmentation: By Drug Class
    • 6.5.1 Europe Antibiotic Drugs Market, By Drug Class Overview
    • 6.5.2 Europe Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.5.3 Europe Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.5.4 Europe Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.5.5 Europe Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.5.6 Europe Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6 Europe Antibiotic Drugs Market Segmentation: By Spectrum
    • 6.6.1 Europe Antibiotic Drugs Market, By Spectrum Overview
    • 6.6.2 Europe Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.6.3 Europe Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7 Europe Antibiotic Drugs Market Segmentation: By Indication
    • 6.7.1 Europe Antibiotic Drugs Market, By Indication Overview
    • 6.7.2 Europe Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.7.3 Europe Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.7.4 Europe Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.7.5 Europe Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 6.7.6 Europe Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.8 Europe Antibiotic Drugs Market Segmentation: By Country
    • 6.8.1 Germany Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.1.1 Germany Antibiotic Drugs Market, By Drug Class
      • 6.8.1.2 Germany Antibiotic Drugs Market, By Spectrum
      • 6.8.1.3 Germany Antibiotic Drugs Market, By Indication
    • 6.8.2 United Kingdom Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.2.1 United Kingdom Antibiotic Drugs Market, By Drug Class
      • 6.8.2.2 United Kingdom Antibiotic Drugs Market, By Spectrum
      • 6.8.2.3 United Kingdom Antibiotic Drugs Market, By Indication
    • 6.8.3 France Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.3.1 France Antibiotic Drugs Market, By Drug Class
      • 6.8.3.2 France Antibiotic Drugs Market, By Spectrum
      • 6.8.3.3 France Antibiotic Drugs Market, By Indication
    • 6.8.4 Italy Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.4.1 Italy Antibiotic Drugs Market, By Drug Class
      • 6.8.4.2 Italy Antibiotic Drugs Market, By Spectrum
      • 6.8.4.3 Italy Antibiotic Drugs Market, By Indication
    • 6.8.5 Spain Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.5.1 Spain Antibiotic Drugs Market, By Drug Class
      • 6.8.5.2 Spain Antibiotic Drugs Market, By Spectrum
      • 6.8.5.3 Spain Antibiotic Drugs Market, By Indication
    • 6.8.6 Rest of Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 6.8.6.1 Rest of Europe Antibiotic Drugs Market, By Drug Class
      • 6.8.6.2 Rest of Europe Antibiotic Drugs Market, By Spectrum
      • 6.8.6.3 Rest of Europe Antibiotic Drugs Market, By Indication

7. Asia-Pacific Antibiotic Drugs Market: Historic and Forecast (2019-2029)

  • 7.1 Asia-Pacific Antibiotic Drugs Market: Snapshot
  • 7.2 Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
  • 7.3 Asia-Pacific Antibiotic Drugs Market: Key Factors
  • 7.4 Asia-Pacific Antibiotic Drugs Market: Segment Analysis
  • 7.5 Asia-Pacific Antibiotic Drugs Market Segmentation: By Drug Class
    • 7.5.1 Asia-Pacific Antibiotic Drugs Market, By Drug Class Overview
    • 7.5.2 Asia-Pacific Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.5.3 Asia-Pacific Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.5.4 Asia-Pacific Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.5.5 Asia-Pacific Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.5.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6 Asia-Pacific Antibiotic Drugs Market Segmentation: By Spectrum
    • 7.6.1 Asia-Pacific Antibiotic Drugs Market, By Spectrum Overview
    • 7.6.2 Asia-Pacific Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.6.3 Asia-Pacific Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7 Asia-Pacific Antibiotic Drugs Market Segmentation: By Indication
    • 7.7.1 Asia-Pacific Antibiotic Drugs Market, By Indication Overview
    • 7.7.2 Asia-Pacific Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.7.3 Asia-Pacific Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.7.4 Asia-Pacific Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.7.5 Asia-Pacific Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 7.7.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.8 Asia-Pacific Antibiotic Drugs Market Segmentation: By Country
    • 7.8.1 China Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 7.8.1.1 China Antibiotic Drugs Market, By Drug Class
      • 7.8.1.2 China Antibiotic Drugs Market, By Spectrum
      • 7.8.1.3 China Antibiotic Drugs Market, By Indication
    • 7.8.2 Japan Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 7.8.2.1 Japan Antibiotic Drugs Market, By Drug Class
      • 7.8.2.2 Japan Antibiotic Drugs Market, By Spectrum
      • 7.8.2.3 Japan Antibiotic Drugs Market, By Indication
    • 7.8.2 India Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 7.8.2.1 India Antibiotic Drugs Market, By Drug Class
      • 7.8.2.2 India Antibiotic Drugs Market, By Spectrum
      • 7.8.2.3 India Antibiotic Drugs Market, By Indication
    • 7.8.3 Rest of Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
      • 7.8.3.1 Rest of Asia-Pacific Antibiotic Drugs Market, By Drug Class
      • 7.8.3.2 Rest of Asia-Pacific Antibiotic Drugs Market, By Spectrum
      • 7.8.3.3 Rest of Asia-Pacific Antibiotic Drugs Market, By Indication

8. Middle-East & Africa Antibiotic Drugs Market: Historic and Forecast (2019-2029)

  • 8.1 Middle-East & Africa Antibiotic Drugs Market: Snapshot
  • 8.2 Middle-East & Africa Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
  • 8.3 Middle-East & Africa Antibiotic Drugs Market: Key Factors
  • 8.4 Middle-East & Africa Antibiotic Drugs Market: Segment Analysis
  • 8.5 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Drug Class
    • 8.5.1 Middle-East & Africa Antibiotic Drugs Market, By Drug Class Overview
    • 8.5.2 Middle-East & Africa Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.5.3 Middle-East & Africa Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.5.4 Middle-East & Africa Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.5.5 Middle-East & Africa Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.5.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Spectrum
    • 8.6.1 Middle-East & Africa Antibiotic Drugs Market, By Spectrum Overview
    • 8.6.2 Middle-East & Africa Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.6.3 Middle-East & Africa Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Indication
    • 8.7.1 Middle-East & Africa Antibiotic Drugs Market, By Indication: Overview
    • 8.7.2 Middle-East & Africa Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.7.3 Middle-East & Africa Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.7.4 Middle-East & Africa Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.7.5 Middle-East & Africa Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
    • 8.7.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact Assessment of Market Dynamics on the Global Antibiotic Drugs Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Porter's Five Forces Analysis

  • 10.1 Porter's Five Forces Model

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Antibiotic Drugs Market
  • 11.4 Company Profiles
    • 11.4.1 Abbott Laboratories
    • 11.4.2 Johnson & Johnson
    • 11.4.3 Pfizer
    • 11.4.4 GSK PLC
    • 11.4.5 Novartis AG
    • 11.4.6 Roche Holding AG
    • 11.4.7 Bayer AG
    • 11.4.8 Merck & Co., Inc.
    • 11.4.9 Viatris Inc.
    • 11.4.10 Cipla